Massive dengue drug trial aims to stop deadly progression
NCT ID NCT07543458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This large study tests several treatments in people hospitalized with moderate or severe dengue. The goal is to find safe, affordable drugs that prevent the disease from getting worse and help patients recover faster. Over 8,800 participants across multiple sites will be enrolled to reduce the burden on hospitals in areas where dengue is common.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARBOVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro de Atención y Diagnóstico de Enfermedades Infecciosas
Bucaramanga, Colombia
-
Chittagong Medical College Hospital
Chittagong, Bangladesh
-
Dhaka Medical College & Hospital
Dhaka, Bangladesh
-
Dhaka North City Corporation Hospital
Dhaka, Bangladesh
-
Fundación Valle del Lili
Cali, Colombia
-
Hospital Queen Elizabeth II, Sabah
Kota Kinabalu, Malaysia
-
Hospital Regional de Loreto
Iquitos, Peru
-
Hospital Universitario Erasmo Meoz
Cúcuta, Colombia
-
Hospital for Tropical Diseases
Ho Chi Minh City, Vietnam
-
Instituto de Infectologia Emílio Ribas
São Paulo, Brazil
-
National Academy of Medical Sciences/Bir Hospital
Kathmandu, Nepal
-
Number 2 Children's Hospital
Ho Chi Minh City, Vietnam
-
Prince of Songkla University in Southern Thailand
Songkhla, Thailand
-
San Lazaro Hospital
Manila, Philippines
-
Siriraj Hospital, Mahidol University
Bangkok, Thailand
-
Sukraraj Tropical and Infectious Disease Hospital
Kathmandu, Nepal
-
Universitas Sumatera Utara
Medan, Indonesia
-
University Malaya Medical Centre
Kuala Lumpur, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental malaria vaccine aims to block parasite growth
- Scientists deliberately infect volunteers with dengue to unlock immune secrets
- Army tests IV antiviral against Kidney-Damaging hemorrhagic fever
- Could a common steroid tame deadly dengue?
- Could papaya leaves help fight dengue? new trial tests the idea
- Placenta cells tested as COVID fighter – but trial stopped early